This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n7http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73567637
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в березні 2001 artículu científicu espublizáu en marzu de 2001 scientific article published on 01 March 2001 wetenschappelijk artikel im März 2001 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q73567637-2244A685-F398-4406-A742-B2B3198A14D7
wdt:P577
2001-03-01T00:00:00Z
p:P407
wds:Q73567637-80A1AA05-075D-49DE-A897-038181EE231D
wdt:P407
wd:Q1860
p:P2093
wds:Q73567637-436EC4B5-39AD-4069-AD0D-92EB0844FBAC wds:Q73567637-23B2E9B9-0851-461A-B7F9-AF57AE4BA75B wds:Q73567637-C1AF6B03-E309-4B56-9D6B-C82C5A5DAE6F
wdt:P2093
M K Andersen J Pedersen-Bjergaard D H Christiansen
rdfs:label
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno
skos:prefLabel
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno
schema:name
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno
p:P1476
wds:Q73567637-BAEACEC3-4AC5-469D-9F39-9EDBDA71AB9B
wdt:P1476
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis
p:P304
wds:Q73567637-4D96FCF4-CCD4-47EE-94C0-8BD1DFDE329B
wdt:P304
1405-1413
p:P31
wds:Q73567637-7021170F-1ADD-4269-8531-01380301173C
wdt:P31
wd:Q13442814
p:P921
wds:Q73567637-25F67022-D797-4A71-8283-A13D96A89F05 wds:Q73567637-DA5B8404-5745-42E8-A823-E5208B10E89B
wdt:P921
wd:Q264118 wd:Q124059385
p:P698
wds:Q73567637-08B46013-8DC2-4F49-9C08-8A3D1BBEC476
wdtn:P698
n10:11230485
wdt:P698
11230485
p:P1433
wds:Q73567637-2059AD66-7C70-44EA-B023-A7F7468551D4
wdt:P1433
wd:Q400292
p:P433
wds:Q73567637-DBC02E0A-16E3-44A0-AD0F-58AD97D9FF7E
p:P478
wds:Q73567637-CA0D2DF7-0F69-4F1B-8461-6E9D85AE0C85
wdt:P433
5
wdt:P478
19
p:P356
wds:Q73567637-57DC5CD9-9CE9-4661-B5FB-5E230797A334
wdtn:P356
n7:JCO.2001.19.5.1405
wdt:P356
10.1200/JCO.2001.19.5.1405